Injective (INJ) is currently priced at $3.03, reflecting a 4.60% increase over the past 24 hours. The price has fluctuated between a low of $2.89 and a high of $3.06 during this period, indicating a stable daily range of 0.17%.

Trading volume over the last 24 hours stands at approximately $46.5 million, which corresponds to a volume-to-market cap ratio of 15.33%. This suggests a healthy trading activity relative to its market capitalization, supporting a bullish sentiment.

Analyzing the hourly moving averages, the 8 SMA is at $2.98 (+1.60%), while the 13 SMA is at $2.96 (+2.22%). These upward trends in short-term moving averages indicate a positive momentum in the market.

The 1-hour RSI is currently at 74, suggesting that INJ is in overbought territory, which could signal a potential short-term pullback. Conversely, the 7-day RSI at 50 indicates neutral momentum, reflecting a balance between buyers and sellers over a longer timeframe.

From a price change perspective, INJ has seen a 6.75% increase over the past week, supported by a 5.05% rise over the last 14 days. However, the 30-day change shows a slight decline of -0.93%, indicating some recent bearish pressure that could affect longer-term sentiment.

Given the all-time high of $52.62 reached in March 2024, current prices are significantly lower, suggesting potential upside for long-term investors. However, the overbought conditions indicated by the 1-hour RSI may pose risks for short-term traders.

Considering the overall analysis, the recommendation for Injective (INJ) is to Hold. The combination of strong short-term price action and potential overbought conditions warrants caution, while longer-term prospects remain positive.